AG0038YC

133550-30-8 | (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide

AG0038YC

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	133550-30-8
Catalog Number	AG0038YC(AGN-PC-0PK1DG)
Chemical Name	(E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide
IUPAC Name	(E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide
InChI	InChI=1S/C17H14N2O3/c18-10-14(8-13-6-7-15(20)16(21)9-13)17(22)19-11-12-4-2-1-3-5-12/h1-9,20-21H,11H2,(H,19,22)/b14-8+
InChI Key	TUCIOBMMDDOEMM-RIYZIHGNSA-N
MDL Number	MFCD00236452
Molecular Formula	C17H14N2O3
Molecular Weight	294.3047
SMILES	C(C1=CC=CC=C1)NC(C(=CC1=CC(=C(C=C1)O)O)C#N)=O
Synonyms	AG 490, AG-490, AG490, alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide, n-benzyl-3,4-dihydroxy-benzylidenecyanoacetamide, tyrphostin AG-490, tyrphostin B42, 133550-30-8, Tyrphostin B42, AG-490, Tyrphostin AG 490, AG 490, AG490, (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide, Tyrphostin AG490, tyrphostin AG-490, AG-490 (Tyrphostin B42), alpha-Cyano-(3,4-dihydroxy)-N-benzylcinnamide, N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide, (2E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide, 134036-52-5, CHEMBL56543, (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide, (2E)-2-CYANO-3-(3,4-DIHYDROXYPHENYL)-N-(PHENYLMETHYL)-2-PROPENAMIDE, SMR001230665, SR-01000076153, 2-Cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)-2-propenamide, MFCD00236452, n-benzyl-3,4-dihydroxy-benzylidenecyanoacetamide, Tyrphostin,AG490, N-Benzyl-3,4-dihydroxy-alpha-cyanocinnamide, xy-phenyl)-acrylamide, Tocris-0414, Tyrphostin deriv. 42, AC1NS5BM, BiomolKI_000025, Lopac-T-3434, BiomolKI2_000033, Tyrphostin AG 490, solid, Lopac0_001166, SCHEMBL93682, BMK1-D1, BSPBio_001396, MLS002153172, MLS006011256, BDBM4313, GTPL5916, DTXSID5040960, NOCAS_40960, AOB6474, EX-A118, EX-A464, CHEBI:131968, BCPP000424, HMS1361F18, HMS1791F18, HMS1989F18, HMS2231N13, HMS3229M15, HMS3402F18, HMS3678G11, ZINC2557947, ABP000823, AG-490/AG490, EI-272, s1143, SBB063097, ZINC02557947, AKOS015888137, BCP9000246, CCG-100629, LP01166, QC-8950, RL01530, IDI1_033866, SMP2_000154, NCGC00016014-01, NCGC00016014-02, NCGC00016014-03, NCGC00016014-04, NCGC00016014-05, NCGC00016014-06, NCGC00016014-07, NCGC00016014-09, NCGC00016014-10, NCGC00024576-01, NCGC00024576-02, NCGC00024576-03, NCGC00024576-04, NCGC00024576-05, NCGC00024576-06, 4CA-0122, 4CA-0125, AJ-40079, AN-16810, (E)-N-Benzyl-2-cyano-3-(3,4-dihydro, RT-016167, EU-0101166, SW219272-1, X7479, EC-000.2082, S-7697, T 3434, alpha-Cyano-(3,4-dihydroxy)-N-benzylcinnamamide, C-18451, I01-0327, J-500741, SR-01000076153-1, SR-01000076153-3, BRD-K47105409-001-05-3, AG-490 , 133550-30-8, (2E)-3-(3,4-dihydroxyphenyl)-2-cyano-N-benzylprop-2-enamide, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamideAG 490, 2-Propenamide,2-cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)-, (E)-2-CYANO-3-(3,4-DIHYDROPHENYL)-N-(PHENYLMETHYL)-2-PROPENAMIDE, 2-PROPENAMIDE, 2-CYANO-3-(3,4-DIHYDROXYPHENYL)-N-(PHENYLMETHYL)-, (2E)-, 2-Propenamide, D0FY0R, D0GZ7B, cc-365, C17H14N2O3, ACN-039822, CID5328779, A-Cyano-(3,4-dihydroxy)-N-benzylcinnamide, A4139, T2962, A10047, C095512, (N-benzyl-N-cyano-3-(3,4-dihydroxyphenyl)acrylamide, N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide, AG-490, 99%, an inhibitor of EGFR - 100MG 100mg,

Complexity	460
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Exact Mass	294.1g/mol
Formal Charge	0
Heavy Atom Count	22
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	294.31g/mol
Monoisotopic Mass	294.1g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	93.4A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	2.4

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H317-H319
Packing Group	Ⅲ
Precautionary statements	P280-P305+P351+P338
UN Code	UN 2811

Certificate of Analysis

Lot Number